Esperion Therapeutics
ESPR
#6752
Rank
A$0.87 B
Marketcap
A$3.66
Share price
-4.06%
Change (1 day)
51.67%
Change (1 year)

EPS for Esperion Therapeutics (ESPR)

EPS in 2025 (TTM): A-$0.79

According to Esperion Therapeutics's latest financial reports the company's current EPS (TTM) is A-$0.70. In 2024 the company made an earnings per share (EPS) of A-$0.32 an increase over its 2023 EPS that were of A-$2.98.

EPS history for Esperion Therapeutics from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$0.79142.7%
2024A-$0.32-89.15%
2023A-$2.98-40.28%
2022A-$5.00-62.87%
2021A-$13.4680.38%
2020A-$7.4650.14%
2019A-$4.97-53.18%
2018A-$10.617.41%
2017A-$9.88110.81%
2016A-$4.6947.35%
2015A-$3.180.89%
2014A-$3.15

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.91-372.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$60.70-8,724.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
A-$8.36 1,088.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
A-$0.27-62.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
A-$0.15-78.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$3.83-644.00%๐Ÿ‡บ๐Ÿ‡ธ USA